(Q77425336)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Adenosine myocardial protection: preliminary results of a phase II clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

main subject

phase II clinical trial

1 reference

R M Mentzer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

V Birjiniuk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Khuri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J E Lowe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

P S Rahko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R D Weisel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

H A Wellons

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M L Barker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

R D Lasley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

643-9; discussion 649-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.

5 December 2019

cites work

1 reference

12 December 2020

Phase 2 studies of adenosine cardioplegia

1 reference

12 December 2020

Effects of low-dose adenosine on myocardial performance after coronary artery bypass surgery.

1 reference

12 December 2020

Adenosine enhanced preservation of myocardial function and energetics. Possible involvement of the adenosine A1 receptor system

1 reference

12 December 2020

Clinical evidence of myocardial stunning in patients undergoing CABG surgery.

1 reference

12 December 2020

Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.

1 reference

12 December 2020

Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts

1 reference

12 December 2020

Salutary effects of exogenous adenosine administration on in vivo myocardial stunning.

1 reference

12 December 2020

Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size

1 reference

12 December 2020

Myocardial stunning: a therapeutic conundrum

1 reference

12 December 2020

Pretreatment of human myocardium with adenosine during open heart surgery.

1 reference

12 December 2020

Adenosine effectively controls pulmonary hypertension after cardiac operations.

1 reference

12 December 2020

Phase 1 human trial of adenosine-potassium cardioplegia.

1 reference

12 December 2020

Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence

1 reference

12 December 2020

Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits

1 reference

12 December 2020

Preconditioning of human myocardium with adenosine during coronary angioplasty

1 reference

12 December 2020

Myocardial perfusion imaging during adenosine-induced coronary hyperemia

1 reference

12 December 2020

Adenosine as an antiarrhythmic agent

1 reference

12 December 2020

Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery

1 reference

12 December 2020

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

1 reference

12 December 2020

Adenosine attenuates in vivo myocardial stunning with minimal effects on cardiac energetics.

1 reference

12 December 2020

Myocardial 'stunning' in man

1 reference

12 December 2020

10.1097/00000658-199905000-00006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10235522%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

1 reference